GV 2017 GP, L.L.C.
SEC insider (Form 3/4/5 filer). CIK 0001733338. 10% Owner at Ethos Technologies Inc. (LIFE) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in MOUNTAIN VIEW, CA.
Companies GV 2017 GP, L.L.C. has filed insider reports for
- Ethos Technologies Inc. (LIFE): 10% Owner
- Verve Therapeutics, Inc. (VERV): 10% Owner
GV 2017 GP, L.L.C.
CIK: 0001733338
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jan 30, 2026LIFE
Ethos Technologies Inc.
SaleIndirect89.7K shares at avg. $19.00$1.7M - Jan 30, 2026LIFE
Ethos Technologies Inc.
ConversionIndirect3.3M shares- - Jan 30, 2026LIFE
Ethos Technologies Inc.
ConversionIndirect571.9K shares- - Jan 30, 2026LIFE
Ethos Technologies Inc.
SaleIndirect1.8M shares at avg. $19.00$33.4M - Jan 30, 2026LIFE
Ethos Technologies Inc.
ConversionIndirect1.8M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect4.3M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect1.8M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect6.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 |  LIFE Ethos Technologies Inc. | Sale | 89,676 | $19.00 | $1,703,844 | Indirect |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | Conversion | 3,287,925 | - | $0 | Indirect |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | Conversion | 571,907 | - | $0 | Indirect |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | Sale | 1,755,632 | $19.00 | $33,357,008 | Indirect |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | Conversion | 1,755,632 | - | $0 | Indirect |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Tender Offer | 4,260,047 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 1,800,000 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 6,108,442 | - | - | Indirect |
1-8 of 8 transactions